UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029508
Receipt number R000033701
Scientific Title Characteristics of mitral valve leaflet length in patients with pectus excavatum: a singlecenter cross-sectional study
Date of disclosure of the study information 2017/10/17
Last modified on 2023/03/18 10:56:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Characteristics of mitral valve leaflet length in patients with pectus excavatum: a singlecenter cross-sectional study

Acronym

Mitral leaflet length in pectus excavatum

Scientific Title

Characteristics of mitral valve leaflet length in patients with pectus excavatum: a singlecenter cross-sectional study

Scientific Title:Acronym

Mitral leaflet length in pectus excavatum

Region

Japan


Condition

Condition

pectus excavatum

Classification by specialty

Cardiology Chest surgery Adult
Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the characteristics of mitral leaflet lengths in pectus excavatum

Basic objectives2

Others

Basic objectives -Others

the characteristics of mitral leaflet lengths in pectus excavatum

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

mitral valve leaflet lengths

Key secondary outcomes

Ratio of mitral P2 length/A2 length
Haller CT index


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Pectus excavatum patients who underwent transthoracic echocardiogram between November 2012 and March 2014

Key exclusion criteria

Inavailability of accurate measurement of mitral P2 or A2 length

Target sample size

81


Research contact person

Name of lead principal investigator

1st name Yoichi
Middle name
Last name Ajiro

Organization

National Hospital Organization Yokohama Medical Center

Division name

Department of Cardiology

Zip code

245-8575

Address

3-60-2 Harajuku, Totsuka-ku, Yokohama-shi, Kanagawa, 245-8575, Japan

TEL

+81-45-851-2621

Email

you617bacchus@gmail.com


Public contact

Name of contact person

1st name Yoichi
Middle name
Last name Ajiro

Organization

National Hospital Organization Yokohama Medical Center

Division name

Department of Cardiology

Zip code

245-8575

Address

3-60-2 Harajuku, Totsuka-ku, Yokohama-shi, Kanagawa, 245-8575, Japan

TEL

+81-45-851-2621

Homepage URL


Email

you617bacchus@gmail.com


Sponsor or person

Institute

Department of Cardiology, National Hospital Organization Yokohama Medical Center

Institute

Department

Personal name



Funding Source

Organization

Clinical Research Division of National Hospital Organization Yokohama Medical Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Yokohama Medical Center

Address

3-60-2 Harajuku, Totsuka-ku, Yokohama-shi, Kanagawa, 245-8575, Japan

Tel

+81-45-851-2621

Email

chikenk@hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構 横浜医療センター


Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 17 Day


Related information

URL releasing protocol

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0212165#sec013

Publication of results

Published


Result

URL related to results and publications

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0212165

Number of participants that the trial has enrolled

81

Results

The characteristic features of the shorter posterior mitral leaflet, the longer anterior mitral leaflet, the shorter coaptation depth, and the longer papillary muscle tethering length in patients with PE was demonstrated. This finding might provide a clue regarding the etiology of mitral valve prolapse in PE at its possible earliest form.

Results date posted

2020 Year 04 Month 13 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2019 Year 02 Month 11 Day

Baseline Characteristics

TThirty-five consecutive patients who were diagnosed with PE and who underwent transthoracic echocardiography between November 2012 and March 2014 were registered. Moreover, 46 healthy individuals with no history of heart failure, atrial fibrillation, myocardial infarction, cardiomyopathy, pericardial disease, or valvular heart disease from the same period were registered as normal controls.

Participant flow

Participants were enrolled with obtaining informed consent by opt-out method

Adverse events

no adverse events

Outcome measures

The P2 and A2 lengths were separately compared between 2 groups: older than 16 years and 16 years or younger. Furthermore, the correlations between actual P2 or A2 lengths and Haller computed tomography index, an index of chest deformity, were investigated in patients with PE exclusively.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 04 Month 05 Day

Date of IRB

2017 Year 04 Month 05 Day

Anticipated trial start date

2017 Year 05 Month 09 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

(1) the actual P2 and A2 leaflet lengths were compared between normal controls and PE patients older than 16 years; (2) the actual P2 and A2 leaflet lengths were compared between 4 normal controls and 7 age- and sex-matched PE patients 16 years or younger individually (no statistical analysis was conducted due to the small sample number); (3) the A2/P2 ratio, which was calculated to reduce the influence of the growth period, was compared between PE patients older than 16 years and those 16 years or younger; (4) to evaluate the correlation between the extent of chest deformity and the mitral leaflet lengths, the Spearman rank correlation coefficients between the Haller CT index and the actual P2 and A2 mitral leaflet lengths in PE patients older than 16 years and between the Haller CT index and the A2/P2 ratio in all PE patients were calculated.


Management information

Registered date

2017 Year 10 Month 11 Day

Last modified on

2023 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033701


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name